Tae Min Kim

High titers of anti‐HBs prevent rituximab‐related viral reactivation in resolved hepatitis B patient with non‐Hodgkin's lymphoma

D. Heo, Jung-Hwan Yoon, Y. Kim, 2016, Journal of medical virology.

Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies

B. Kim, Sung-Soo Yoon, B. Keam, 2006, Clinical transplantation.

Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy

Sung-Soo Yoon, P. G. Choe, N. Kim, 2023, Cancer research and treatment.

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study

Y. Kim, Jeong‐Hoon Lee, S. Yu, 2023, Journal of Korean medical science.

Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

A. Mansfield, J. Neal, R. Heist, 2023, Clinical lung cancer.